ES2136167T3 - Composiciones de idebenona para tratar la enfermedad de alzheimer. - Google Patents
Composiciones de idebenona para tratar la enfermedad de alzheimer.Info
- Publication number
- ES2136167T3 ES2136167T3 ES94303847T ES94303847T ES2136167T3 ES 2136167 T3 ES2136167 T3 ES 2136167T3 ES 94303847 T ES94303847 T ES 94303847T ES 94303847 T ES94303847 T ES 94303847T ES 2136167 T3 ES2136167 T3 ES 2136167T3
- Authority
- ES
- Spain
- Prior art keywords
- disease
- idebenone
- compositions
- treat alzheimer
- alzheimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
UNA COMPOSICION PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER, CUYA COMPOSICION CONTIENE IDEBENONA EN UNA CANTIDAD QUE OSCILA ENTRE 50 MG O MAS EN UNA DOSIS. LA ADMINISTRACION ORAL DE "IDEBENONA" A UN PACIENTE CON LA ENFERMEDAD DE ALZHEIMER, A UNA DOSIS DE 50 MG O MAS POR CADA ADMINISTRACION, RESULTA EFICAZ PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14815493 | 1993-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2136167T3 true ES2136167T3 (es) | 1999-11-16 |
Family
ID=15446472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94303847T Expired - Lifetime ES2136167T3 (es) | 1993-06-18 | 1994-05-27 | Composiciones de idebenona para tratar la enfermedad de alzheimer. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0629400B1 (es) |
JP (1) | JPH0761923A (es) |
AT (1) | ATE184788T1 (es) |
CA (1) | CA2125822A1 (es) |
DE (1) | DE69420776T2 (es) |
DK (1) | DK0629400T3 (es) |
ES (1) | ES2136167T3 (es) |
GR (1) | GR3032041T3 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19549262C2 (de) * | 1995-02-08 | 1997-10-09 | Martin Dr Kohlmeier | Präparat zur Abschätzung des Entstehungsrisikos eines beschleunigten Verlustes kognitiver Fähigkeiten |
EP0788793A1 (en) * | 1996-02-01 | 1997-08-13 | Takeda Chemical Industries, Ltd. | Idebenone for the treatment of dementia |
US6271266B1 (en) | 1996-07-11 | 2001-08-07 | Takeda Chemical Industries, Ltd. | Use of idebenone and analogues against β amyloid induced cytotoxicity |
AU5495398A (en) * | 1997-01-17 | 1998-08-07 | Takeda Chemical Industries Ltd. | Idebenone containing combination agent for treating alzheimer's disease |
US5962535A (en) * | 1997-01-17 | 1999-10-05 | Takeda Chemical Industries, Ltd. | Composition for alzheimer's disease |
WO1999007355A1 (fr) * | 1997-08-12 | 1999-02-18 | Takeda Chemical Industries, Ltd. | Preparation contenant de l'idebenone pour administration par voie percutanee |
JP2003226639A (ja) * | 2002-01-31 | 2003-08-12 | Hisamitsu Pharmaceut Co Inc | 神経成長因子活性増強剤としてのビタミンk類を含む医薬組成物およびその使用 |
AR055453A1 (es) * | 2004-01-06 | 2007-08-22 | Creactivar S A | Uso de la idebenona en una composicion destinada a ser aplicada sobre la piel y composicion que la comprende |
HUE033304T2 (en) | 2005-06-01 | 2017-11-28 | Bioelectron Tech Corp | Redoxactive therapeutic agents for the treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
JP5374162B2 (ja) | 2006-02-22 | 2013-12-25 | エジソン ファーマシューティカルズ, インコーポレイテッド | ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節 |
BRPI0918139A2 (pt) | 2008-09-10 | 2015-12-01 | Edison Pharmaceuticals Inc | composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso |
WO2014035356A1 (en) * | 2012-08-31 | 2014-03-06 | Mahmut Bilgic | Tablet formulations comprising a quinone derivative active agent |
CN113024369A (zh) | 2015-12-17 | 2021-06-25 | Ptc医疗公司 | 用于治疗氧化应急障碍的化合物 |
EP4351545A1 (en) | 2021-06-07 | 2024-04-17 | Katholieke Universiteit Leuven | Idebenone in the treatment of drug resistant epilepsy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08768B2 (ja) * | 1989-08-24 | 1996-01-10 | 武田薬品工業株式会社 | 神経成長因子分泌誘導剤 |
-
1994
- 1994-05-27 EP EP94303847A patent/EP0629400B1/en not_active Expired - Lifetime
- 1994-05-27 DE DE69420776T patent/DE69420776T2/de not_active Expired - Fee Related
- 1994-05-27 ES ES94303847T patent/ES2136167T3/es not_active Expired - Lifetime
- 1994-05-27 AT AT94303847T patent/ATE184788T1/de not_active IP Right Cessation
- 1994-05-27 DK DK94303847T patent/DK0629400T3/da active
- 1994-06-08 JP JP6125606A patent/JPH0761923A/ja active Pending
- 1994-06-14 CA CA002125822A patent/CA2125822A1/en not_active Abandoned
-
1999
- 1999-12-02 GR GR990403128T patent/GR3032041T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0629400T3 (da) | 2000-02-14 |
DE69420776T2 (de) | 2000-05-18 |
JPH0761923A (ja) | 1995-03-07 |
CA2125822A1 (en) | 1994-12-19 |
ATE184788T1 (de) | 1999-10-15 |
EP0629400A1 (en) | 1994-12-21 |
GR3032041T3 (en) | 2000-03-31 |
DE69420776D1 (de) | 1999-10-28 |
EP0629400B1 (en) | 1999-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
KR940703676A (ko) | 알렌드로네이트를 사용한 치근막 질환의 치료방법(Treatment of periodontal disease with alendronate) | |
IL98810A0 (en) | Pharmaceutical compositions containing flupirtine for combating muscular tension disorders and their preparation | |
ES2136167T3 (es) | Composiciones de idebenona para tratar la enfermedad de alzheimer. | |
GB2285219B (en) | Use of norastemizole for the treatment of allergic disorders | |
ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
ES555118A0 (es) | Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas. | |
WO1998025573A3 (en) | The use of celastrol to treat alzheimer's disease | |
KR890003390A (ko) | 골다공증 및 관련된 장해의 치료방법 | |
DE69835461D1 (de) | Anti-arrhythmische Zusammensetzungen und Behandlungsverfahren | |
GR3017855T3 (en) | Use of lithium in the treatment or prophylaxis of Molluscum contagiosum. | |
IL118833A (en) | Sertraline for use as a medicament in the treatment of post-myocardial infarction patients | |
SG54157A1 (en) | Use of ketorolac for treatment of periodontal disease | |
MX9303074A (es) | Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer. | |
IT1246050B (it) | Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. | |
ES2101982T3 (es) | Composicion conteniendo una alta dosis de vitamina a. | |
IL103499A0 (en) | Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients | |
MX9709684A (es) | Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel. | |
IT1244714B (it) | Uso della benzidamina per il trattamento della placca dentaria | |
IT1251993B (it) | Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 629400 Country of ref document: ES |